Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization

Fertility and Sterility

Volumn 71, Issue 5, 1999, Pages 808-814

  Enskog, Anders ^a   Henriksson, Malin ^a   Unander, Margaretha ^a   Nilsson, Lars ^a   Brännström, Mats ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Age; Allergy; Estradiol; Follicle; IVF; OHSS

Indexed keywords

BUSERELIN; GONADOTROPIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYNDROME;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; FERTILIZATION IN VITRO; GONADAL STEROID HORMONES; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0032968177     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00090-4     Document Type: Article

References (27)

1. Zalel Y., Caspi B., Ben-hur H., Insler V. Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease. Am J Obstet Gynecol. 167:1992;122-124.
2. Howles C., Loumaye E., Giroud D., Luyet G. Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF a multicentre European phase III study . Hum Reprod. 9:1994;424-430.
3. Forman R., Fries N., Testart J., Belaisvh-Allart J., Hazout A., Frydman R. Evidence of an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril. 49:1988;118-122.
4. Caspi E., Ron-El R., Golan A., Nachum H., Herman A., Soffer Y., et al. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. Fertil Steril. 51:1989;95-99.
5. Agrawal R., Chimusoro K., Payne N., Spuy Z., Jacobs H. Severe ovarian hyperstimulation syndrome serum and ascitic fluid concentrations of vascular endothelial growth factor . Curr Opin Obstet Gynecol. 9:1997;141-144.
6. Mola J.L., Baumgardner G., Goldfarb J., Friedlander M. Ovarian hyperstimulation syndrome pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumor necrosis factor-a cannot predict its occurrence . Hum Reprod. 11:1996;1377-1380.
7. Knox G. Antihistamine blockade of the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 118:1974;992-994.
8. Schenker J., Polishuk W. The role of prostaglandins in ovarian hyperstimulation syndrome. Eur J Obstet Gynaecol Reprod Biol. 6:1976;47-52.
9. Haning A.J., Austin C., Carlson I., Kuzama D., Zweibel W. Plasma estradiol is superior to ultrasound and urinary estradiol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril. 40:1983;31-36.
10. Mordel N., Schenker J. Gonadotrophin-releasing hormone agonist and ovarian hyperstimulation syndrome in assisted reproduction. Hum Reprod. 8:1993;2009-2014.
11. Blankstein J., Pariente C., Shalev J., Lunenfeld B., Saadon T., Serr D., et al. Ovarian hyperstimulation syndrome prediction by number and size of preovulatory ovarian follicles . Fertil Steril. 47:1987;597-602.
12. Navot D., Relou A., Birkenfeld A., Rabinowitz R., Brzezinski A., Margalioth E. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 159:1988;210-215.
13. Delvigne A., Demoulin A., Smitz J., Donnez J., Koninckx P., Dhont M., et al. The ovarian hyperstimulation syndrome in in-vitro fertilization a Belgian multicentric study. I. Clinical and biological features . Hum Reprod. 8:1993;1353-1360.
14. Golan A., Ron-El R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome an update review . Obstet Gynecol Surv. 44:1989;430-440.
15. Favero A.D., Tonato F., Roila F. Issues in the measurement of nausea. Br J Cancer Suppl. 66:1992;S69-S71.
16. Wikland M., Borg J., Hamberger L., Svalander P. Simplification of IVF minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction . Hum Reprod. 9:1994;1430-1436.
17. Elchalal U., Schenker J. The pathophysiology of ovarian hyperstimulation syndrome - views and ideas. Hum Reprod. 12:1997;1129-1137.
18. Forman R., Frydman R., Egan D., Ross C., Barlow D. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization a European series and a proposal for prevention . Fertil Steril. 53:1990;502-509.
19. Asch R., Li H.-P., Balmaceda J., Weckstein L., Stone S. Severe ovarian hyperstimulation syndrome in assisted reproductive technology definition of high risk groups . Hum Reprod. 6:1991;1395-1399.
20. Padilla S., Zamaria S., Baramki T., Garcia J. Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fertil Steril. 53:1990;365-367.
21. Gianaroli L., Ferraretti A., Fiorentino A. The ovarian hyperstimulation syndrome. Reprod Med Rev. 5:1996;169-184.
22. Navot D., Bergh P., Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies prevention and treatment . Fertil Steril. 58:1992;249-259.
23. Krishnan K., Vijayalakshmi S., Sheth A. Presence of low molecular weight LH/hCG and FSH binding inhibitors in human and sheep ovaries. Indian J Exp Biol. 21:1983;229.
24. Juliusson S., Aldenborg F., Enerbäck L. Proteinase content of mast cells of nasal mucosa; effects of natural allergen exposure and local corticosteroid treatment. Allergy. 50:1995;15-22.
25. Nakamura Y., Smith M., Krishna A., Terranova P. Increased number of mast cells in the dominant follicle of the cow relationships among luteal, stromal, and hilar regions . Biol Reprod. 37:1987;546-549.
26. Lewis C., Warnes G., Wang X., Matthews C. Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women. Fertil Steril. 53:1990;1097-1099.
27. Tal J., Paz B., Samberg I., Lazarov N., Sharf M. Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate menotropin therapy for induction of ovulation . Fertil Steril. 44:1985;342-349.